Also categorized in BoardNews:
Why Should We Care About Corporate Interlocks?
x hide permanently

A Handful of Allergan's Top Shareholders Want to Bring Back the Old CEO as Chairman

Business Insider
  • A handful of large Allergan shareholders are privately discussing bringing back former Allergan CEO David Pyott in a chairman role, according to people familiar with the matter.
  • It's unclear if investors have formally reached out to Pyott yet to discuss a return to the company...
Mentions: Investment Management Investors